SIRT3 and hepatocellular carcinoma: Moreover, SIRT3 overexpression resulted in increased level of phosphorylated-c-Jun and Bim which is downstream target of AP-1 in HCC cells exposed to chemotherapeutic agents (Figure 5C–5E).